Sequence-Specific DNA Binders for the Therapy of Mitochondrial Diseases
Springer Verlag, Singapore
978-981-16-8435-7 (ISBN)
This work willattract readers’ interest because it paves the way for a transgene-free chemical gene therapy for mitochondrial diseases. The book includes a detailed description of experimental procedures, especially compound synthesis. This description helps readers to have a clear image of the author’s studies and to perform similar and extended studies themselves.
Takuya Hidaka received his Ph.D. in 2021 under the supervision of Professor Hiroshi Sugiyama at Kyoto University for his chemical biology research on artificial control of DNA transcription and replication using DNA-binding molecules. He has been a research fellow of the Japan Society for the Promotion of Science (JSPS) from 2021 and is working on the development of proteome analysis techniques based on single-molecule imaging.
General Introduction.- Creation of Synthetic Ligand for Mitochondrial DNA sequence Recognition and Promoter-Specific Transcription Suppression.- Allele-Specific Replication Inhibition of Mitochondrial DNA by MITO-PIP Conjugated with Alkylation Reagent.- Enhanced Nuclear Accumulation of Pyrrole–Imidazole Polyamides by Incorporation of the Tri-arginine Vector.
Erscheinungsdatum | 07.01.2022 |
---|---|
Reihe/Serie | Springer Theses |
Zusatzinfo | 47 Illustrations, color; 3 Illustrations, black and white; XIII, 94 p. 50 illus., 47 illus. in color. |
Verlagsort | Singapore |
Sprache | englisch |
Maße | 155 x 235 mm |
Themenwelt | Naturwissenschaften ► Biologie ► Genetik / Molekularbiologie |
Naturwissenschaften ► Biologie ► Zellbiologie | |
Naturwissenschaften ► Chemie | |
Technik ► Maschinenbau | |
Schlagworte | DNA alkylation • DNA-binding molecules • DNA mutation • Mitochondrial diseases • Pyrrole–imidazole polyamides |
ISBN-10 | 981-16-8435-9 / 9811684359 |
ISBN-13 | 978-981-16-8435-7 / 9789811684357 |
Zustand | Neuware |
Haben Sie eine Frage zum Produkt? |
aus dem Bereich